Olverembatinib-based therapy in patients with transformed chronic myeloid leukemia in lymphoid blast phase or relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia: A multicentre retrospective study
Bao M et al. Clin Lymphoma Myeloma Leuk, May 2026
Link to full abstract